IRIS Accounts Production v24.2.0.383 14598758 Board of Directors 17.1.23 31.1.24 31.1.24 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh145987582023-01-16145987582024-01-31145987582023-01-172024-01-31145987582023-01-1614598758ns15:EnglandWales2023-01-172024-01-3114598758ns14:PoundSterling2023-01-172024-01-3114598758ns10:Director12023-01-172024-01-3114598758ns10:PrivateLimitedCompanyLtd2023-01-172024-01-3114598758ns10:SmallEntities2023-01-172024-01-3114598758ns10:AuditExempt-NoAccountantsReport2023-01-172024-01-3114598758ns10:SmallCompaniesRegimeForDirectorsReport2023-01-172024-01-3114598758ns10:SmallCompaniesRegimeForAccounts2023-01-172024-01-3114598758ns10:FullAccounts2023-01-172024-01-3114598758ns10:Director22023-01-172024-01-3114598758ns10:RegisteredOffice2023-01-172024-01-3114598758ns5:CurrentFinancialInstruments2024-01-3114598758ns5:ShareCapital2024-01-3114598758ns5:RetainedEarningsAccumulatedLosses2024-01-3114598758ns5:PlantMachinery2023-01-172024-01-3114598758ns5:ComputerEquipment2023-01-172024-01-3114598758ns5:PlantMachinery2024-01-3114598758ns5:ComputerEquipment2024-01-3114598758ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-01-31
REGISTERED NUMBER: 14598758 (England and Wales)









BICUSPID LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD

17 JANUARY 2023 TO 31 JANUARY 2024






BICUSPID LIMITED (REGISTERED NUMBER: 14598758)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 17 JANUARY 2023 TO 31 JANUARY 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


BICUSPID LIMITED

COMPANY INFORMATION
FOR THE PERIOD 17 JANUARY 2023 TO 31 JANUARY 2024







DIRECTORS: S Cocan
Dr M Cocan





REGISTERED OFFICE: Station House
North Street
Havant
Hampshire
PO9 1QU





REGISTERED NUMBER: 14598758 (England and Wales)





ACCOUNTANTS: Morris Crocker
Chartered Accountants
Station House
North Street
Havant
Hampshire
PO9 1QU

BICUSPID LIMITED (REGISTERED NUMBER: 14598758)

BALANCE SHEET
31 JANUARY 2024

Notes £    £   
FIXED ASSETS
Tangible assets 4 3,636

CURRENT ASSETS
Debtors 5 17,570
Investments 6 40,358
Cash at bank 26,202
84,130
CREDITORS
Amounts falling due within one year 7 51,938
NET CURRENT ASSETS 32,192
TOTAL ASSETS LESS CURRENT
LIABILITIES

35,828

PROVISIONS FOR LIABILITIES 909
NET ASSETS 34,919

CAPITAL AND RESERVES
Called up share capital 100
Retained earnings 34,819
SHAREHOLDERS' FUNDS 34,919

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 October 2024 and were signed on its behalf by:




S Cocan - Director


BICUSPID LIMITED (REGISTERED NUMBER: 14598758)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 17 JANUARY 2023 TO 31 JANUARY 2024

1. STATUTORY INFORMATION

Bicuspid Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover represents the provision of dental services provided in the year.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Dental equipment - 20% on reducing balance
Computer equipment - 20% on cost

Financial instruments
Debtors and cash at bank: Trade and other debtors are recognised at the settlement amount due after any trade discount offered. prepayments are valued at the amount prepaid net of any trade discounts due. Cash at bank and in hand includes cash on deposit or in a current account.

Creditors and provisions: Creditors and provisions are recognised where there is a present obligation resulting from a past event that will probably result in the transfer of economic benefits to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

BICUSPID LIMITED (REGISTERED NUMBER: 14598758)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 17 JANUARY 2023 TO 31 JANUARY 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was NIL.

4. TANGIBLE FIXED ASSETS
Dental Computer
equipment equipment Totals
£    £    £   
COST
Additions 3,070 1,386 4,456
At 31 January 2024 3,070 1,386 4,456
DEPRECIATION
Charge for period 565 255 820
At 31 January 2024 565 255 820
NET BOOK VALUE
At 31 January 2024 2,505 1,131 3,636

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade debtors 14,834
Other debtors 2,736
17,570

6. CURRENT ASSET INVESTMENTS
£   
Other 40,358

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade creditors 161
Taxation and social security 40,209
Other creditors 11,568
51,938